Hematology/Oncology

Top Story

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy
February 12, 2016

Black women appeared less likely than those from other racial backgrounds to benefit from neoadjuvant chemotherapy, according to results of a database study.

In addition, black women appeared less likely to achieve pathologic complete response for triple-negative or HER-2–positive breast cancer.

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

February 12, 2016
The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national…

Lung cancer expert named to NCI board

February 12, 2016
Roman Perez-Soler, MD, chairman and chief of the department of oncology at Montefiore Einstein Center for Cancer Care, has been named to NCI’s board of scientific…
In the Journals

Pretransplant melanoma associated with melanoma, mortality after transplant

February 12, 2016
Researchers found an association between pretransplant melanoma and increased melanoma-specific mortality, overall mortality and incident melanoma after transplant…
In the Journals

IV pegylated asparaginase shows promise for pediatric ALL

February 12, 2016
IV pegylated asparaginase yielded similar efficacy as intramuscular native Escherichia coli L-asparaginase without increasing toxicity in pediatric patients with newly…
More News Headlines »
CME

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Meeting News CoverageVideo

VIDEO: Novel prediction model accurately determines survival in gastric cancer

February 5, 2016
More »
Featured
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan